Agranulocytosis: Causes, Symptoms and Treatment
Agranulocytosis is a severe deficiency of neutrophil granulocytes in the blood, which critically weakens the immune system and can cause life-threatening infections.
Things worth knowing about "Agranulocytosis"
Agranulocytosis is a severe deficiency of neutrophil granulocytes in the blood, which critically weakens the immune system and can cause life-threatening infections.
What is Agranulocytosis?
Agranulocytosis is a serious blood disorder characterized by an extreme reduction or complete absence of neutrophil granulocytes – a critical type of white blood cell. Neutrophils are a key component of the human immune system and play an essential role in defending the body against bacterial and fungal infections. A severe deficiency of these cells leaves the body almost defenseless against pathogens and can rapidly lead to life-threatening conditions.
Medically, agranulocytosis is defined as a neutrophil count below 500 cells per microliter of blood. When levels fall below 100 cells per microliter, the condition is considered especially dangerous.
Causes
Agranulocytosis can arise from various causes. A fundamental distinction is made between drug-induced and non-drug-induced forms.
Drug-Induced Agranulocytosis
This is the most common cause. Certain medications can inhibit the production of granulocytes in the bone marrow or trigger an immune-mediated destruction of these cells. Drug groups most frequently involved include:
- Antipsychotics (e.g., clozapine)
- Antithyroid drugs (e.g., methimazole, propylthiouracil)
- Antibiotics (e.g., cotrimoxazole, chloramphenicol)
- Non-steroidal anti-inflammatory drugs (NSAIDs) (e.g., metamizole)
- Cytostatic agents (cancer medications)
Other Causes
- Autoimmune diseases (e.g., systemic lupus erythematosus)
- Viral infections (e.g., Epstein-Barr virus, HIV)
- Bone marrow disorders (e.g., aplastic anemia, leukemia)
- Severe sepsis
- Congenital forms (e.g., severe congenital neutropenia)
Symptoms
The symptoms of agranulocytosis primarily result from the loss of immune defense. Since the body is no longer able to effectively fight pathogens, severe infections develop rapidly. Typical signs include:
- High fever (often the first warning sign)
- Chills and rigors
- Severe sore throat and inflammation of the oral mucosa (mucositis)
- Ulcers in the mouth and throat area
- General weakness and fatigue
- Rapidly progressing infections of the skin, lungs, or other organs
- In the worst case: sepsis (blood poisoning)
Important note: Because the inflammatory response is severely impaired, typical signs of infection (e.g., pus formation) may be absent or very mild.
Diagnosis
Agranulocytosis is diagnosed through a blood test using a differential blood count, which identifies and quantifies the different types of white blood cells. A diagnosis is confirmed when neutrophil counts are found to be critically low.
To determine the underlying cause, additional investigations may be required:
- Bone marrow biopsy (to assess blood cell production)
- Testing for autoantibodies
- Virological testing
- Detailed medication history (review of all current and recent drugs)
Treatment
Treatment of agranulocytosis depends on the underlying cause and the severity of the condition.
Immediate Measures
- Discontinuation of the causative drug (if drug-induced)
- Hospital admission
- Protective measures against infection (isolation, strict hygiene protocols)
Medical Therapy
- Broad-spectrum intravenous antibiotics in the presence of fever or signs of infection
- G-CSF (granulocyte colony-stimulating factor): medication to stimulate granulocyte production in the bone marrow (e.g., filgrastim)
- Antifungal therapy in case of fungal infections
- In severe cases: bone marrow transplantation
When detected early and treated promptly, the prognosis for agranulocytosis is favorable in many cases. However, without treatment, the condition can become life-threatening very quickly.
References
- Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Annals of Internal Medicine, 2007; 146(9): 657-665.
- Kaufman DW, Kelly JP, Levy M, Shapiro S. The Drug Etiology of Agranulocytosis and Aplastic Anemia. Oxford University Press, 1991.
- Dale DC. How I manage patients with neutropenia. British Journal of Haematology, 2023; 200(3): 264-275.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryVitamin kinetics
Nutrient absorption test
Conflict management
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Agranulocytosis-en